JP4452426B2 - 靭帯置換構造物並びにその製造方法 - Google Patents
靭帯置換構造物並びにその製造方法 Download PDFInfo
- Publication number
- JP4452426B2 JP4452426B2 JP2001570204A JP2001570204A JP4452426B2 JP 4452426 B2 JP4452426 B2 JP 4452426B2 JP 2001570204 A JP2001570204 A JP 2001570204A JP 2001570204 A JP2001570204 A JP 2001570204A JP 4452426 B2 JP4452426 B2 JP 4452426B2
- Authority
- JP
- Japan
- Prior art keywords
- cells
- ligament
- fiber
- matrix
- skeleton
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000003041 ligament Anatomy 0.000 title claims abstract description 29
- 238000004519 manufacturing process Methods 0.000 title description 2
- 239000000835 fiber Substances 0.000 claims abstract description 65
- 238000000034 method Methods 0.000 claims abstract description 24
- 230000008439 repair process Effects 0.000 claims abstract description 11
- 238000009954 braiding Methods 0.000 claims description 12
- 230000035755 proliferation Effects 0.000 claims description 8
- 238000002054 transplantation Methods 0.000 claims description 3
- 238000010899 nucleation Methods 0.000 claims description 2
- 239000004753 textile Substances 0.000 claims description 2
- 230000002062 proliferating effect Effects 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 12
- 210000004027 cell Anatomy 0.000 description 49
- 239000011159 matrix material Substances 0.000 description 33
- 210000001264 anterior cruciate ligament Anatomy 0.000 description 32
- 210000001519 tissue Anatomy 0.000 description 24
- 229920000642 polymer Polymers 0.000 description 19
- 210000002950 fibroblast Anatomy 0.000 description 13
- 229920000747 poly(lactic acid) Polymers 0.000 description 12
- 239000004626 polylactic acid Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 229920000954 Polyglycolide Polymers 0.000 description 11
- 230000015556 catabolic process Effects 0.000 description 9
- 238000006731 degradation reaction Methods 0.000 description 9
- 210000000963 osteoblast Anatomy 0.000 description 9
- 108010067306 Fibronectins Proteins 0.000 description 7
- 102000016359 Fibronectins Human genes 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- -1 polyethylene terephthalate Polymers 0.000 description 7
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000013461 design Methods 0.000 description 6
- 239000005020 polyethylene terephthalate Substances 0.000 description 6
- 229920004934 Dacron® Polymers 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- 238000001523 electrospinning Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000036755 cellular response Effects 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 239000007943 implant Substances 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 208000025674 Anterior Cruciate Ligament injury Diseases 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 229930182816 L-glutamine Natural products 0.000 description 2
- 229920001410 Microfiber Polymers 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000034530 PLAA-associated neurodevelopmental disease Diseases 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 210000004748 cultured cell Anatomy 0.000 description 2
- 229920006237 degradable polymer Polymers 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 239000012894 fetal calf serum Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000003658 microfiber Substances 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000000399 orthopedic effect Effects 0.000 description 2
- 238000012667 polymer degradation Methods 0.000 description 2
- 229920005594 polymer fiber Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000002791 soaking Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 230000009772 tissue formation Effects 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 229920000049 Carbon (fiber) Polymers 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- 101001027128 Homo sapiens Fibronectin Proteins 0.000 description 1
- 206010061223 Ligament injury Diseases 0.000 description 1
- 241000906034 Orthops Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000011316 allogeneic transplantation Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000003416 augmentation Effects 0.000 description 1
- 229920002988 biodegradable polymer Polymers 0.000 description 1
- 239000004621 biodegradable polymer Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 239000004917 carbon fiber Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 239000012598 cell culture matrix Substances 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- MKXKFYHWDHIYRV-UHFFFAOYSA-N flutamide Chemical compound CC(C)C(=O)NC1=CC=C([N+]([O-])=O)C(C(F)(F)F)=C1 MKXKFYHWDHIYRV-UHFFFAOYSA-N 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009940 knitting Methods 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000000426 patellar ligament Anatomy 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/08—Muscles; Tendons; Ligaments
Landscapes
- Health & Medical Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
- Lining Or Joining Of Plastics Or The Like (AREA)
- Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19199900P | 2000-03-24 | 2000-03-24 | |
| US60/191,999 | 2000-03-24 | ||
| PCT/US2001/009079 WO2001072241A1 (en) | 2000-03-24 | 2001-03-22 | Ligament replacement constructs and methods for production and use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007161999A Division JP4897583B2 (ja) | 2000-03-24 | 2007-06-20 | 靭帯置換構造物並びにその製造方法および使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003530912A JP2003530912A (ja) | 2003-10-21 |
| JP4452426B2 true JP4452426B2 (ja) | 2010-04-21 |
Family
ID=22707811
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001570204A Expired - Fee Related JP4452426B2 (ja) | 2000-03-24 | 2001-03-22 | 靭帯置換構造物並びにその製造方法 |
| JP2007161999A Expired - Fee Related JP4897583B2 (ja) | 2000-03-24 | 2007-06-20 | 靭帯置換構造物並びにその製造方法および使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007161999A Expired - Fee Related JP4897583B2 (ja) | 2000-03-24 | 2007-06-20 | 靭帯置換構造物並びにその製造方法および使用 |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1272127B1 (enExample) |
| JP (2) | JP4452426B2 (enExample) |
| AT (1) | ATE381912T1 (enExample) |
| AU (2) | AU2001249322B2 (enExample) |
| CA (1) | CA2403983C (enExample) |
| DE (1) | DE60132079T2 (enExample) |
| DK (1) | DK1272127T3 (enExample) |
| ES (1) | ES2299481T3 (enExample) |
| WO (1) | WO2001072241A1 (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8486143B2 (en) | 2009-05-22 | 2013-07-16 | Soft Tissue Regeneration, Inc. | Mechanically competent scaffold for ligament and tendon regeneration |
| US8945218B2 (en) | 2000-03-24 | 2015-02-03 | Drexel University | Ligament and tendon replacement constructs and methods for production and use thereof |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030212456A1 (en) * | 2002-05-09 | 2003-11-13 | John Lipchitz | Implant for tissue repair |
| US8177839B2 (en) * | 2006-12-27 | 2012-05-15 | Shriners Hospitals For Children | Woven and/or braided fiber implants and methods of making same |
| EP2131880B1 (en) | 2007-02-20 | 2012-08-08 | Shriners Hospitals for Children | In vivo hydraulic fixation including bio-rivets using biocompatible expandable fibers |
| JP5492097B2 (ja) | 2008-02-22 | 2014-05-14 | マイメディクス，インコーポレイテッド | 手首、手及びその他の靱帯置換術又は修復術のために適切なバイオステープル |
| EP2291143B1 (en) | 2008-05-16 | 2020-07-08 | Mimedx, Inc. | Medical constructs of twisted lengths of collagen fibers and methods of making same |
| CA2740008C (en) | 2008-10-09 | 2017-01-31 | Mimedx, Inc. | Methods of making biocomposite medical constructs and related constructs including artificial tissues, vessels and patches |
| US9757132B2 (en) * | 2010-03-24 | 2017-09-12 | Biorez, Inc. | Mechanically competent scaffold for rotator cuff and tendon augmentation |
| CA2829339C (en) | 2011-03-08 | 2018-10-16 | Mimedx, Inc. | Collagen fiber ribbons with integrated fixation sutures and methods of making the same |
| US9694106B2 (en) | 2011-07-11 | 2017-07-04 | Mimedx Group, Inc. | Synthetic collagen threads for cosmetic uses including skin wrinkle treatments and associated methods |
| US8986378B2 (en) | 2011-11-02 | 2015-03-24 | Mimedx Group, Inc. | Implantable collagen devices and related methods and systems of making same |
| US9433489B2 (en) | 2013-03-12 | 2016-09-06 | Soft Tissue Regeneration, Inc. | Absorbable synthetic braided matrix for breast reconstruction and hernia repair |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4792336A (en) * | 1986-03-03 | 1988-12-20 | American Cyanamid Company | Flat braided ligament or tendon implant device having texturized yarns |
| US5263984A (en) * | 1987-07-20 | 1993-11-23 | Regen Biologics, Inc. | Prosthetic ligaments |
| EP0306018A1 (en) * | 1987-09-04 | 1989-03-08 | Bio-Products, Inc. | Tendon/ligament substitutes composed of long, parallel, non-antigenic tendon/ligament fibers |
| US5078744A (en) * | 1987-09-04 | 1992-01-07 | Bio-Products, Inc. | Method of using tendon/ligament substitutes composed of long, parallel, non-antigenic tendon/ligament fibers |
| US5376118A (en) * | 1989-05-10 | 1994-12-27 | United States Surgical Corporation | Support material for cell impregnation |
| JP3493199B2 (ja) * | 1993-07-07 | 2004-02-03 | スミス アンド ネフュー ピーエルシー | 埋込型プロステーシス、キットおよびそれを製造するための装置 |
| EP0677297B1 (en) * | 1993-09-24 | 2000-12-13 | Takiron Co. Ltd. | Implantation material |
| GB2282328B (en) * | 1993-09-29 | 1997-10-08 | Johnson & Johnson Medical | Absorbable structures for ligament and tendon repair |
| JPH10505250A (ja) * | 1994-06-06 | 1998-05-26 | ケース ウエスターン リザーブ ユニバーシティ | 組織再生のためのバイオマトリックス |
| US5718012A (en) * | 1996-05-28 | 1998-02-17 | Organogenesis, Inc. | Method of strength enhancement of collagen constructs |
| CA2252860C (en) * | 1996-05-28 | 2011-03-22 | 1218122 Ontario Inc. | Resorbable implant biomaterial made of condensed calcium phosphate particles |
-
2001
- 2001-03-22 EP EP01922531A patent/EP1272127B1/en not_active Expired - Lifetime
- 2001-03-22 WO PCT/US2001/009079 patent/WO2001072241A1/en not_active Ceased
- 2001-03-22 DK DK01922531T patent/DK1272127T3/da active
- 2001-03-22 AT AT01922531T patent/ATE381912T1/de active
- 2001-03-22 AU AU2001249322A patent/AU2001249322B2/en not_active Ceased
- 2001-03-22 CA CA002403983A patent/CA2403983C/en not_active Expired - Lifetime
- 2001-03-22 DE DE60132079T patent/DE60132079T2/de not_active Expired - Lifetime
- 2001-03-22 ES ES01922531T patent/ES2299481T3/es not_active Expired - Lifetime
- 2001-03-22 AU AU4932201A patent/AU4932201A/xx active Pending
- 2001-03-22 JP JP2001570204A patent/JP4452426B2/ja not_active Expired - Fee Related
-
2007
- 2007-06-20 JP JP2007161999A patent/JP4897583B2/ja not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8945218B2 (en) | 2000-03-24 | 2015-02-03 | Drexel University | Ligament and tendon replacement constructs and methods for production and use thereof |
| US8486143B2 (en) | 2009-05-22 | 2013-07-16 | Soft Tissue Regeneration, Inc. | Mechanically competent scaffold for ligament and tendon regeneration |
| US8758437B2 (en) | 2009-05-22 | 2014-06-24 | Soft Tissue Regeneration, Inc. | Mechanically competent scaffold for ligament and tendon regeneration |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2403983C (en) | 2008-02-12 |
| WO2001072241A1 (en) | 2001-10-04 |
| AU2001249322B2 (en) | 2004-10-14 |
| DK1272127T3 (da) | 2008-04-28 |
| EP1272127B1 (en) | 2007-12-26 |
| DE60132079D1 (de) | 2008-02-07 |
| JP4897583B2 (ja) | 2012-03-14 |
| CA2403983A1 (en) | 2001-10-04 |
| DE60132079T2 (de) | 2008-12-18 |
| JP2007289727A (ja) | 2007-11-08 |
| EP1272127A4 (en) | 2004-03-03 |
| EP1272127A1 (en) | 2003-01-08 |
| AU4932201A (en) | 2001-10-08 |
| ES2299481T3 (es) | 2008-06-01 |
| JP2003530912A (ja) | 2003-10-21 |
| ATE381912T1 (de) | 2008-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4897583B2 (ja) | 靭帯置換構造物並びにその製造方法および使用 | |
| US8945218B2 (en) | Ligament and tendon replacement constructs and methods for production and use thereof | |
| Cooper et al. | Fiber-based tissue-engineered scaffold for ligament replacement: design considerations and in vitro evaluation | |
| EP0707498B1 (en) | Implantable prosthesis, kit and device for manufacturing the same | |
| Nehrer et al. | Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro | |
| US7108721B2 (en) | Tissue regrafting | |
| Ouyang et al. | Knitted poly-lactide-co-glycolide scaffold loaded with bone marrow stromal cells in repair and regeneration of rabbit Achilles tendon | |
| Shields et al. | Mechanical properties and cellular proliferation of electrospun collagen type II | |
| Li et al. | Biocomposites reinforced by fibers or tubes as scaffolds for tissue engineering or regenerative medicine | |
| Cavallaro et al. | Collagen fabrics as biomaterials | |
| US6689166B2 (en) | Hybrid nanofibril matrices for use as tissue engineering devices | |
| Farè et al. | In vitro study on silk fibroin textile structure for anterior cruciate ligament regeneration | |
| US20100291178A1 (en) | Multi-phased, biodegradable and osteointegrative composite scaffold for biological fixation of musculoskeletal soft tissue of bone | |
| US20100047309A1 (en) | Graft collar and scaffold apparatuses for musculoskeletal tissue engineering and related methods | |
| Zhao et al. | Healing improvement after rotator cuff repair using gelatin-grafted poly (L-lactide) electrospun fibrous membranes | |
| Ge et al. | Characterization of knitted polymeric scaffolds for potential use in ligament tissue engineering | |
| Toyokawa et al. | Electrospun synthetic polymer scaffold for cartilage repair without cultured cells in an animal model | |
| EP1282452A1 (en) | Tissue regrafting | |
| AU2001249322A1 (en) | Ligament replacement constructs and methods for production and use thereof | |
| EP2155112A1 (en) | Fully synthetic implantable multi-phased scaffold | |
| Mäkisalo et al. | Reconstruction of anterior cruciate ligament with carbon fiber: An experimental study on pigs | |
| Cooper Jr | Design optimization and in vivo evaluation of a tissue-engineered anterior cruciate ligament replacement | |
| Zhu et al. | In Vivo Study of Ligament‐Bone Healing after Anterior Cruciate Ligament Reconstruction Using Autologous Tendons with Mesenchymal Stem Cells Affinity Peptide Conjugated Electrospun Nanofibrous Scaffold | |
| Baldino et al. | Bone–tendon interface | |
| Wu et al. | 3D functional scaffolds for tendon tissue engineering |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050322 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050621 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050628 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050921 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060411 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060711 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060719 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20061006 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20070220 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070620 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20070525 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20070807 |
|
| A912 | Re-examination (zenchi) completed and case transferred to appeal board |
Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20071026 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090728 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090731 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091204 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100201 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4452426 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130205 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140205 Year of fee payment: 4 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |